IDN 5390: an oral taxane candidate for protracted treatment schedules.
Pratesi G, Laccabue D, Lanzi C, Cassinelli G, Supino R, Zucchetti M, Frapolli R, D'Incalci M, Bombardelli E, Morazzoni P, Riva A, Zunino F.
Pratesi G, et al. Among authors: morazzoni p.
Br J Cancer. 2003 Mar 24;88(6):965-72. doi: 10.1038/sj.bjc.6600784.
Br J Cancer. 2003.
PMID: 12644838
Free PMC article.